In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lumara Health Inc.

http://www.lumarahealth.com/

Latest From Lumara Health Inc.

ObsEva Stays Afloat By Selling Lead Women’s Health Asset To XOMA

The Swiss firm has divested yet another one of its key programs in a bid to stave off insolvency and remain a listed company, forcing it to focus solely on a pre-IVF drug candidate.

Deals Gynecology & Urology

Biocon Claims Edge For Adalimumab In US

Biocon, which is set to close its deal with Viatris shortly, says it is in a “very good position” to vie for a share of the adalimumab biosimilar pie in the US and has had encouraging preliminary discussions with payers.

Biosimilars Strategy

Humira Biosimilar Drumbeats: Biocon Claims Edge For Adalimumab In US

Biocon, which is set to close its deal with Viatris shortly, says it is in a “very good position” to vie for a share of the adalimumab biosimilar pie in the US and has had encouraging preliminary discussions with payers.

Commercial Biosimilars

New Ferring Head Laments Woeful Neglect Of Women's Health

After fighting for years to bridge the gender health gap where many women receive poorer treatment than men from academia and non-profits, Kelle Moley has moved into pharma with Ferring to further her vision.

Clinical Trials Gynecology & Urology
See All

Company Information

  • Other Names / Subsidiaries
    • Ethex Corporation
    • K-V Pharmaceutical Company (KV Pharmaceutical)
    • Ther-Rx Corporation
UsernamePublicRestriction

Register